Sinovac Biotech Ltd.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SVA research report →
Companywww.sinovacbio.com
Sinovac Biotech Ltd. , a biopharmaceutical company, focuses in the research, development, manufacture, and commercialization of vaccines against human infectious diseases in the People's Republic of China. The company's product portfolio includes vaccines against hepatitis A and B; hand, foot, and mouth diseases caused by enterovirus 71 (EV71); seasonal influenza; H5N1 and H1N1 pandemic influenza; coronavirus; varicella; and mumps.
- CEO
- Wei Dong Yin
- IPO
- 2003
- Employees
- 1,959
- HQ
- Beijing, CN
Price Chart
Valuation
- Market Cap
- $464.94M
- P/E
- -6.45
- P/S
- 1.04
- P/B
- 0.07
- EV/EBITDA
- 83.96
- Div Yield
- 1700.15%
Profitability
- Gross Margin
- 59.51%
- Op Margin
- -121.96%
- Net Margin
- -22.29%
- ROE
- -1.13%
- ROIC
- -4.34%
Growth & Income
- Revenue
- $448.27M · -69.97%
- Net Income
- $-99,918,000 · -187.75%
- EPS
- $-1.06 · -198.15%
- Op Income
- $-546,724,000
- FCF YoY
- 96.45%
Performance & Tape
- 52W High
- $6.47
- 52W Low
- $6.47
- 50D MA
- $6.47
- 200D MA
- $6.47
- Beta
- 0.00
- Avg Volume
- 0
Get TickerSpark's AI analysis on SVA
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Apr 17, 26 | Li Jiaqiang | other | 0 |
| Mar 18, 26 | LI JING (NMN) | other | 0 |
| Mar 18, 26 | Yang Guang (Helen) | other | 0 |
| Mar 18, 26 | GAO QIANG (NMN) | other | 0 |
| Mar 18, 26 | WANG NAN | other | 0 |
| Mar 18, 26 | WANG YU (NMN) | other | 0 |
| Mar 18, 26 | JIAO SHUGE | other | 0 |
| Mar 18, 26 | LO YUK LAM | other | 0 |
| Mar 18, 26 | QIU YU MIN | other | 0 |
| Mar 18, 26 | Yan Andrew Y | other | 0 |
Our SVA Coverage
We haven't published any research on SVA yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate SVA Report →